Ozempic reduces knee osteoarthritis pain by almost half: Study

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of reported pain among patients with knee osteoarthritis and obesity. The study funded by Novo Nordisk, the manufacturer of Ozempic and Wegovy, involved 407 participants…